MidAC for Acute Myeloid Leukaemia (AML)

What's in this booklet? 

Mitoxantrone and cytarabine (also known as cytosine arabinoside or Ara-C) are two licensed drugs that can be used together as a combination therapy (named MidAC) for the treatment of acute myeloid leukaemia (AML).

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Digital downloads

To access an instant download of our MidAC for Acute myeloid leukaemia (AML) information booklet, please click here (opens as a PDF file). 

Each booklet takes us approximately six months to write and is supplied free of charge to patients, families and hospitals across the UK. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can.